Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics that address significant unmet need for patients living with immune-mediated diseases. Its lead product candidate, budoprutug, is a clinical-stage anti-CD19 monoclonal antibody (mAb) designed to deplete CD19-positive B cells. By targeting CD19, budoprutug has the potential to provide reductions in B cells and pathogenic autoantibodies. The Company is developing budoprutug for the treatment of primary membranous nephropathy (pMN), immune thrombocytopenia (ITP), and systemic lupus erythematosus (SLE). The Company is in Phase II clinical trial of budoprutug for pMN, Phase Ib/IIa clinical trial for ITP, and Phase Ib clinical trial of budoprutug for SLE. The Company is also developing CLYM116, an anti-APRIL (A Proliferation-Inducing Ligand) monoclonal antibody being developed for the treatment of immunoglobulin A nephropathy.
Find out what a historical investment in Climb Bio Inc would be worth today using our CLYM stock calculator.
Buying CLYM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Climb Bio Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CLYM
What is the ticker symbol of Climb Bio Inc?
The ticker symbol for Climb Bio Inc is CLYM.
How much is one share of CLYM?
One share of CLYM is valued at $9.28 as of 20 November 2026.
What is the market capitalisation of Climb Bio Inc CLYM?
As of 20 November 2026 Climb Bio Inc has a market cap of $546.27M.
What is the 52-week high for Climb Bio Inc stock?
The Climb Bio Inc 52-week high stock price is $18.33.
What is the 52-week low for Climb Bio Inc stock?
The Climb Bio Inc 52-week low stock price is $1.64.
Can I buy CLYM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CLYM shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CLYM on Stake
Buy CLYM from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CLYM from only US$10 with fractional shares